Perioperative Management of Oral Anticoagulants and Antiplatelet Therapy in Hand and Wrist Surgery.

J Am Acad Orthop Surg · Aug 01 2023 · Review

Gallant GG, Matzon JL, Beredjiklian PK, Rivlin M

From the Hand Surgeon Rothman Orthopaedics, Thomas Jefferson University Rothman Orthopaedics, Sidney Kimmel Medical…

Hand & Upper Extremity

SUMMARY — THE REDUCTIONThis review analyzes current evidence on managing anticoagulants/antiplatelets around hand and wrist surgery, since no clear guidelines exist and both continuation and cessation carry risks.
Abstract, as published

There is wide variability in the management of patients on antithrombotic therapy requiring surgery of the hand and wrist. There are no specific guidelines regarding whether to temporarily cease or continue oral anticoagulants and antiplatelet agents. Discontinuation of these medications before surgery can lead to perioperative thromboembolic or ischemic events. On the other hand, continuation can lead to intraoperative or postoperative bleeding complications. This review discusses various anticoagulants and antiplatelet agents with special considerations for their management, analyzes the current literature, summarizes current recommendations, and provides direction for additional research.

Featured in the 2026-08-14 issue.

← Reverse Neurocutaneous Flap Based on the Dorsal Branch of the…Scaphoid fracture and nonunion: new directions. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.